Our Recommendations
- Consolidated HIV guidelines for prevention, treatment, service delivery & monitoring (2021)
- Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection (2016)
- Guidelines: updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring (2021)
- Manual for male circumcision under local anaesthesia and HIV prevention services for adolescent boys and men (2018)
- Updated Recommendations Onservice Delivery For The Treatment And Care Of People Living With HIV. Summary Slides (2021)
New Publications
- Identifying common opportunistic infections among people with advanced HIV disease (2024)
- Leveraging the Learning Insights from HIV Programming for Pregnant and Parenting Adolescent Girls (2023)
- Laboratory and point-of-care diagnostic testing for sexually transmitted infections, including HIV (2023)
- Point-of-care tests for sexually transmitted infections: target product profiles (2023)
- The role of HIV viral suppression in improving individual health and reducing transmission (2023)
Filter
337
Featured
Recommendations
13
New Publications
79
Language
Document type
No document type
120
Guidelines
112
Studies & Reports
59
Fact sheets
22
Infographics
9
Manuals
5
Situation Updates
3
Training Material
2
Resource Platforms
2
Brochures
1
Online Courses
1
Strategic & Response Plan
1
Countries / Regions
Latin America and the Carribbean
7
South Africa
7
Global
5
Africa
5
East and Southern Africa
5
Malawi
3
Asia
3
South–East Asia Region
3
Western and Central Europe
3
Uganda
3
Kenya
2
Lesotho
2
USA
2
Zambia
2
Nepal
1
El Salvador
1
Syria
1
Laos
1
Afghanistan
1
Zimbabwe
1
Philippines
1
Mozambique
1
Cambodia
1
Guinea-Bissau
1
Congo, Democratic Republic of
1
Middle East and North Africa
1
Western Pacific Region
1
North America
1
Jamaica
1
Bangladesh
1
Vietnam
1
Brazil
1
Sri Lanka
1
Russia
1
Yemen
1
Angola
1
Bhutan
1
India
1
Pakistan
1
Authors & Publishers
Publication Years
Category
HIV & STI
38
Policies & Guidelines HIV & TB
8
TB
8
Guidelines
7
Reproductive Health
6
Studies & Reports
5
Hepatitis
3
COVID-19
3
Women & Child Health
3
Capacity Building
3
Gynaecology & Obstetrics
3
Dermatology
2
Virology
2
Family Planning
1
x MEDBOX Issue Brief & Annual Reports x
1
Cervical Cancer
1
Chagas
1
Training Manuals
1
Demograhic Health Surveys DHS
1
Community Health
1
Information, Education and Communication (IEC)
1
Surgery & Anaesthesia
1
Nutrition
1
Maternal Health
1
Leishmaniasis
1
Non-communicable Diseases
1
Pharmacy & Technologies
1
Toolboxes
HIV testing & services
55
Clinical Aspects, Treatment & Prevention
49
Antiretroviral Treatment ART
46
Women
38
Clinical Aspects
36
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
35
ART Drug Resistance
25
Male Circumcision
23
HIV and COVID-19
23
COVID-19
22
Treatment Guidelines HIV
21
Opportunistic Infections
19
Prevention Guidelines
17
HIV service delivery
16
Access to treatment and laboratory
15
Co-Morbidities (except TB)
15
Treatment & Prevention
14
Policies
10
Prophylactic Treatment
10
Adherence
9
Testing Guidelines
8
Global Impact: Socio-economic, health services, TB & HIV
7
General Reports
6
Children & Adolescents
5
Community Worker
5
Eastern and Southern Africa
5
Drug resistance
4
Prevention of mother-to-child transmission (PMTCT)
4
Latin America & the Carribean
4
Others
3
Immunization Guidelines
3
Health Worker
3
Policies and guidelines
3
HIV in Key Populations
3
Eastern Europe and central Asia
3
Policies & Strategies
2
Prevention & Control
2
Global
2
Laboratory
2
Universal Health Coverage UHC and 90-90-90 Strategy
2
Country specific documents
2
Gender Aspects
2
TB/HIV
2
Asia and Pacific
2
HIV and coinfection
2
TB/HIV Coinfection
2
Reports & Studies Children HIV
2
Drugs
1
Adults
1
HIV surveillance
1
Substance Use Disorders, Others
1
Inclusion
1
HIV testing & disclosure
1
Transgender People
1
Sexually Transmitted Infections
1
Men who have sex with men (MSM)
1
HIV
1
People who injecting Drugs
1
HIV / AIDS
1
Reports
1
General
1
Clinical Guidelines
1
Online Courses & Resources
1
For Pregnant Women
1
Training, others
1
For Migrants & Refugees
1
Prison & Detention
1
For Older People
1
Hospital Readiness/Essential Health Services
1
COVID-19 Vaccination
1
Long-term Care Facilities
1
TB/COVID-19
1
Community Health Workers CHW
1
HIV &TB
1
Information Refugees Ukraine
1
Zoonoses
1
NTDs
1
Chagas
1
Clinical Aspects & Diagnostics
1
General Aspects
1
Malawi
1
For Community Health Workers
1
Nutrition
1
Research & Access
1
TB
1
Lobby and Advocacy
1
Depression
1
Prisoners
1
The HIV drug resistance report 2021 summarizes findings from 38 countries that had finalized the surveys by the time of this report and shared data with WHO.
Pretreatment HIVDR to non-nucleoside reverse-transcriptase inhibitors (NNRTI) can affect more than 10% of adults starting therapy and is fo...
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released i...
WHO’s antiretroviral treatment (ART) clinic-based acquired drug resistance survey method yields robust estimates of HIV viral suppression and acquired HIV drug resistance in adults, children and adolescents taking both dolutegravir and non-dolutegravir based regimens.
Results are used to inform A...
This implementation brief addresses integration of HIV testing services into family planning (FP) services. It is intended as a practical resource for national health programmes seeking to introduce or scale up HIV testing and linkage to HIV prevention, sexually transmitted infection, and antiretrov...
Testing men for HIV during their partner’s pregnancy can guide couples-based HIV prevention and treatment, but testing rates remain low. We investigated a combination approach, using evidence-based strategies, to increase HIV testing in male partners of HIV-positive and HIV-negative ...
MEDBOX Issue Brief no.18.
The MEDBOX team has compiled a new issue brief on the impact of COVID-19 on PLHIV HIV prevention programmes and treatment for this year's World AIDS Day on 1 December 2021.
Validation of elimination of mother-to-child transmission, or vertical transmission, of HIV, syphilis and hepatitis B virus (HBV), is an attestation that a country has successfully met standard criteria for elimination, or for being at 1 of the 3 levels of achievement on the ‘Path to Elimination...
Adolescent girls and young women (AGYW) remain disproportionately affected by HIV in Eastern and Southern Africa (ESA), with 26 per cent of new infections attributed to this population. AGYW face many personal, social and structural barriers to access, uptake and use of traditional HIV prevention me...
The World Health Organization and the Global Fund to Fight AIDS, Tuberculosis and Malaria are part of a group of agencies working together to accelerate progress towards the health-related SDGs through the Global Action Plan for Healthy Lives and Well-being for All. Understanding patterns of inequal...
This document synthesizes key elements of the World Health Organization (WHO) normative guidance on health policy and system support for community health worker (CHW) programmes and their application for HIV programmes. Building on relevant elements of HIV guidelines, tools and evidence identified b...
Herramienta de estimación de necesidades y costos de la profilaxis preexposición (PrEP). Instruccciones de uso. En particular, calcula 1) el número de personas que se beneficiarían de la PrEP, en cada población relevante; 2) el total de personas que el país o entidad tiene capacidad para cubri...
This joint publication by UNAIDS and WHO emphasizes the importance of integrating HIV prevention, testing, treatment and care and mental health services for people living with HIV. It provides a compilation of tools, best practices, recommendations and guidelines that facilitate the integration of i...
Severe bacterial infections are a leading cause of morbidity and mortality among people with advanced HIV disease, after tuberculosis and cryptococcal disease. For countries to reach the end-AIDS targets for 2030, there is a need to establish a roadmap for managing severe bacterial infections and re...
This technical report summarizes the discussions on the status of programmatic transition to tenofovir, lamivudine and dolutegravir (TLD) in low– and middle- income countries, addressing the best practices and major challenges faced by HIV programmes.
The latest data on safety and efficacy of do...
This technical brief aims to support these trends, accelerated by the COVID-19 pandemic, and improve PrEP uptake, persistence, and effective use by providing implementation guidance for differentiated and simplified service delivery. The brief aims to support a range of stakeholders in planning and ...
